The Diagnostic Imaging Agents Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally.
Browse more detail information about diagnostic imaging agents market:
Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents.
The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
Please download sample copy of diagnostic imaging agents market report if you’d like to receive a soft copy of this brief summary.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453